JPH0515705B2 - - Google Patents
Info
- Publication number
- JPH0515705B2 JPH0515705B2 JP61130006A JP13000686A JPH0515705B2 JP H0515705 B2 JPH0515705 B2 JP H0515705B2 JP 61130006 A JP61130006 A JP 61130006A JP 13000686 A JP13000686 A JP 13000686A JP H0515705 B2 JPH0515705 B2 JP H0515705B2
- Authority
- JP
- Japan
- Prior art keywords
- group
- general formula
- acid addition
- addition salt
- represented
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HU852193A HU195487B (en) | 1985-06-04 | 1985-06-04 | Process for producing quinoline derivatives |
| HU2251-2193/85 | 1985-06-04 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6248668A JPS6248668A (ja) | 1987-03-03 |
| JPH0515705B2 true JPH0515705B2 (2) | 1993-03-02 |
Family
ID=10958222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61130006A Granted JPS6248668A (ja) | 1985-06-04 | 1986-06-04 | キノリン誘導体とその酸付加塩、その製法及びこの化合物を含む薬用組成物 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US4652562A (2) |
| JP (1) | JPS6248668A (2) |
| KR (1) | KR930006775B1 (2) |
| CN (1) | CN1012957B (2) |
| AT (1) | AT392469B (2) |
| AU (1) | AU588883B2 (2) |
| BE (1) | BE904864A (2) |
| CA (1) | CA1266650A (2) |
| CH (1) | CH668069A5 (2) |
| CS (1) | CS257793B2 (2) |
| DD (1) | DD247448A5 (2) |
| DE (1) | DE3618724C2 (2) |
| DK (1) | DK162841C (2) |
| ES (1) | ES8707231A1 (2) |
| FI (1) | FI82451C (2) |
| FR (1) | FR2582835B1 (2) |
| GB (1) | GB2176185B (2) |
| GR (1) | GR861452B (2) |
| HU (1) | HU195487B (2) |
| IL (1) | IL79024A0 (2) |
| IT (1) | IT1204377B (2) |
| NL (1) | NL8601434A (2) |
| NO (1) | NO165635C (2) |
| PH (1) | PH24135A (2) |
| PL (1) | PL146498B1 (2) |
| PT (1) | PT82712B (2) |
| SE (1) | SE466308B (2) |
| SU (1) | SU1398773A3 (2) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6331286B1 (en) | 1998-12-21 | 2001-12-18 | Photogen, Inc. | Methods for high energy phototherapeutics |
| US8974363B2 (en) * | 1997-12-11 | 2015-03-10 | Provectus Pharmatech, Inc. | Topical medicaments and methods for photodynamic treatment of disease |
| US20090117199A1 (en) * | 1998-08-06 | 2009-05-07 | Scott Timothy C | Method of treatment of cancer |
| US8557298B2 (en) * | 1998-08-06 | 2013-10-15 | Provectus Pharmatech, Inc. | Medicaments for chemotherapeutic treatment of disease |
| US7384623B1 (en) | 1998-12-21 | 2008-06-10 | Provectus Pharmatech, Inc. | High energy phototherapeutic agents |
| US20020001567A1 (en) * | 1998-12-21 | 2002-01-03 | Photogen, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| US8470296B2 (en) * | 1998-12-21 | 2013-06-25 | Provectus Pharmatech, Inc. | Intracorporeal medicaments for high energy phototherapeutic treatment of disease |
| EP1719770A3 (en) * | 2000-09-21 | 2008-03-05 | Smithkline Beecham Plc | Quinoline derivatives as antibacterials |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HU165520B (2) * | 1972-05-05 | 1974-09-28 | ||
| IE47458B1 (en) * | 1977-11-07 | 1984-03-21 | Leo Pharm Prod Ltd | Quinolylguanidine derivatives |
-
1985
- 1985-06-04 HU HU852193A patent/HU195487B/hu not_active IP Right Cessation
-
1986
- 1986-05-28 CH CH2153/86A patent/CH668069A5/de not_active IP Right Cessation
- 1986-05-30 DD DD86290766A patent/DD247448A5/de not_active IP Right Cessation
- 1986-06-03 BE BE0/216734A patent/BE904864A/fr not_active IP Right Cessation
- 1986-06-03 PH PH33848A patent/PH24135A/en unknown
- 1986-06-03 CN CN86103688A patent/CN1012957B/zh not_active Expired
- 1986-06-03 KR KR1019860004409A patent/KR930006775B1/ko not_active Expired - Fee Related
- 1986-06-03 AT AT1492/86A patent/AT392469B/de not_active IP Right Cessation
- 1986-06-04 SU SU864027590A patent/SU1398773A3/ru active
- 1986-06-04 PL PL1986259871A patent/PL146498B1/pl unknown
- 1986-06-04 JP JP61130006A patent/JPS6248668A/ja active Granted
- 1986-06-04 CA CA000510779A patent/CA1266650A/en not_active Expired - Lifetime
- 1986-06-04 SE SE8602524A patent/SE466308B/sv not_active IP Right Cessation
- 1986-06-04 AU AU58344/86A patent/AU588883B2/en not_active Ceased
- 1986-06-04 NO NO862230A patent/NO165635C/no unknown
- 1986-06-04 FR FR8608039A patent/FR2582835B1/fr not_active Expired
- 1986-06-04 ES ES555708A patent/ES8707231A1/es not_active Expired
- 1986-06-04 US US06/870,396 patent/US4652562A/en not_active Expired - Fee Related
- 1986-06-04 CS CS864112A patent/CS257793B2/cs unknown
- 1986-06-04 DK DK262186A patent/DK162841C/da not_active IP Right Cessation
- 1986-06-04 GR GR861452A patent/GR861452B/el unknown
- 1986-06-04 IT IT20667/86A patent/IT1204377B/it active
- 1986-06-04 IL IL79024A patent/IL79024A0/xx not_active IP Right Cessation
- 1986-06-04 NL NL8601434A patent/NL8601434A/nl not_active Application Discontinuation
- 1986-06-04 FI FI862381A patent/FI82451C/fi not_active IP Right Cessation
- 1986-06-04 PT PT82712A patent/PT82712B/pt unknown
- 1986-06-04 DE DE3618724A patent/DE3618724C2/de not_active Expired - Fee Related
- 1986-06-04 GB GB08613530A patent/GB2176185B/en not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4282232A (en) | Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof | |
| DE69132961T2 (de) | Styrylsubstituierte heteroarylverbindungen, welche egf-rezeptor-tyrosinkinase inhibieren | |
| JPH04982B2 (2) | ||
| JPS59500130A (ja) | 低酸素性腫瘍細胞用ニトロイミダゾ−ル放射線増感剤およびその組成物 | |
| EP0350448A1 (de) | Biarylverbindungen | |
| DE69523298T2 (de) | Aminostilbazolderivate und medikament | |
| EP0005828A1 (de) | Neue substituierte Phenylpiperazinderivate, diese enthaltende Arzneimittel und Verfahren zu deren Herstellung | |
| JPH0515705B2 (2) | ||
| JP3083544B2 (ja) | 心疾患を予防または治療する薬剤 | |
| US5252567A (en) | Diazine derivatives | |
| US3666860A (en) | Substituted nitroimidazolylthiadiazoles and oxadiazoles as antiprotozoal agents | |
| EP1892245B1 (en) | Antineoplastic compounds and pharmaceutical compositions thereof | |
| JPH11506776A (ja) | 微生物感染の治療方法 | |
| JP2848602B2 (ja) | 新規含フッ素2−ニトロイミダゾールおよびそれを含む放射線増感剤 | |
| AU732722B2 (en) | 2-{4-{4-(4,5-dichloro-2- methylimidazol-1-yl)butyl} -1-piperazinyl}-5-fluoropyrimidine, its preparation and its therapeutic use | |
| US4418062A (en) | Amino derivatives of chloro nitro amino pyrazines useful as adjuncts to radiation therapy | |
| DE4134224C2 (de) | Neue 1-Heterocyclylmethyl-3-nitro-1,2,4-triazole | |
| US3887556A (en) | Antimycotic diphenyl-imidazolyl-pyrimidyl methanes | |
| HU191299B (en) | Process for producing 2/1h/-pyridinone derivatives increasing cardiac action | |
| EP0495749A1 (de) | Bipyridyle | |
| JP2000256327A (ja) | 新規イソキノリン誘導体 | |
| JP2004075565A (ja) | アルキル−8−ニトロキサンチン誘導体 | |
| JPS61143361A (ja) | ニトロピリジン化合物 |